Scarica l'app Stockscreener
9.12
2.46%
-0.23
Dopo l'orario di chiusura:
9.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$9.35
Aprire:
$9.52
Volume 24 ore:
3.19M
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.23B
Reddito:
$24.30M
Utile/perdita netta:
$-145.57M
Rapporto P/E:
-6.8571
EPS:
-1.33
Flusso di cassa netto:
$-149.17M
1 W Prestazione:
-5.00%
1M Prestazione:
+11.63%
6M Prestazione:
+94.46%
1 anno Prestazione:
+198.04%
Intervallo 1D:
$9.06
$10.08
Intervallo di 1 settimana:
$8.88
$10.08
Portata 52W:
$1.03
$11.20
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Confronta TNGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
9.12 | 1.26B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-17 | Iniziato | Jefferies | Buy |
| 2024-04-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Iniziato | Piper Sandler | Overweight |
| 2023-12-08 | Iniziato | B. Riley Securities | Buy |
| 2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 7.6%Here's What Happened - MarketBeat
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing - Yahoo Finance
Highs Report: Is Tango Therapeutics Inc stock a defensive play in 2025Portfolio Performance Report & Risk Managed Investment Signals - moha.gov.vn
Tango Therapeutics (NASDAQ:TNGX) Raised to Buy at Wall Street Zen - MarketBeat
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors - MSN
Stempoint Capital LP Acquires Shares of 208,800 Tango Therapeutics, Inc. $TNGX - MarketBeat
Can Tango Therapeutics (TNGX) climb 37.28% to reach the level Wall Street analysts expect? - MSN
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 4.6%Should You Sell? - MarketBeat
Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat
Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Finviz
Tango Therapeutics CFO Beckman sells $25,281 in stock - MSN
Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st
Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
How interest rate cuts could boost Tango Therapeutics Inc. stockMarket Risk Analysis & Daily Profit Focused Screening - Newser
Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation - Nasdaq
Is Tango Therapeutics Inc. stock near bottom after declineJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser
Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target - Investing.com Nigeria
Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target By Investing.com - Investing.com South Africa
Piper Sandler Healthcare Conference - marketscreener.com
Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics (TNGX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Tango Therapeutics Stock Hold Up When Markets Turn? - Trefis
Retail Trends: How interest rate cuts could boost Tango Therapeutics Inc stockRecession Risk & Fast Exit Strategy with Risk Control - BỘ NỘI VỤ
Tango Therapeutics Inc trading resumes - MSN
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy - MSN
Tango Therapeutics initiated with a Peer Perform at Wolfe Research - MSN
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Tango Therapeutics (NASDAQ:TNGX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Tango Therapeutics launches $100M at-the-market stock offering - MSN
Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High? - MSN
Tango Therapeutics Enters New Sales Agreement with Leerink - The Globe and Mail
Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's
Tango Therapeutics stock hits 52-week high at 9.7 USD By Investing.com - Investing.com Nigeria
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal TestingBuy (TNGX) - Seeking Alpha
Tango Therapeutics stock hits 52-week high at 9.7 USD - Investing.com India
Tango Therapeutics launches new $100 million at-the-market stock offering By Investing.com - Investing.com Nigeria
Tango Therapeutics Inc files for mixed shelf offeringSEC filing - marketscreener.com
Tango Therapeutics files prospectus for resale of 1.7 million shares by selling stockholderSEC filing - marketscreener.com
Tango Therapeutics launches new $100 million at-the-market stock offering - Investing.com Nigeria
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):